Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001678165-25-000002
Filing Date
2025-02-24
Accepted
2025-02-24 11:24:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4745
  Complete submission text file 0001678165-25-000002.txt   6541
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Subject) CIK: 0001427570 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-89741 | Film No.: 25655176
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1040 FIRST AVENUE SUITE 190 NEW YORK NY 10022
Business Address 1040 FIRST AVENUE SUITE 190 NEW YORK NY 10022 212-317-5970
FirstFire Global Opportunities Fund LLC (Filed by) CIK: 0001678165 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G